BiomEdit Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series C
  • (In Progress)

  • Latest Deal Amount
  • $30M

  • Investors
  • 11

BiomEdit General Information

Description

Developer of programmable veterinary biologics designed to address livestock health and productivity challenges as well as chronic diseases in pets. The company offers engineered biological products with programmable therapeutic capabilities, enabling livestock producers and pet healthcare providers to improve animal health outcomes and productivity.

Contact Information

Website
www.biomedit.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1210 Waterway Boulevard
  • Suite 2000
  • Indianapolis, IN 46202
  • United States
+1 (317)
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Vertical(s)
AgTech, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 1210 Waterway Boulevard
  • Suite 2000
  • Indianapolis, IN 46202
  • United States
+1 (317)

BiomEdit Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BiomEdit Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series C) 30-Sep-2026 $30M In Progress Generating Revenue/Not Profitable
6. Grant 21-Oct-2025 Completed Product Development
5. Early Stage VC (Series B) 15-Jul-2025 Completed Product Development
4. Grant 02-Nov-2023 Completed Product Development
3. Early Stage VC (Series A) 15-Feb-2023 Completed Product Development
2. Accelerator/Incubator 11-Apr-2022 Completed Startup
1. Joint Venture 11-Apr-2022 Completed Startup
To view BiomEdit’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BiomEdit Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of programmable veterinary biologics designed to address livestock health and productivity challenges as well
Biotechnology
Indianapolis, IN
30 As of 2026

San Diego, CA
 

Copenhagen, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BiomEdit Competitors (8)

One of BiomEdit’s 8 competitors is Native Microbials, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Native Microbials Venture Capital-Backed San Diego, CA
Bactolife Venture Capital-Backed Copenhagen, Denmark
Novobind Venture Capital-Backed Vancouver, Canada
AnimalBiome Venture Capital-Backed Oakland, CA
Resilient Biotics Venture Capital-Backed Durham, NC
You’re viewing 5 of 8 competitors. Get the full list »

BiomEdit Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BiomEdit Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bezos Earth Fund Impact Investing
AgriZeroNZ Impact Investing Minority
Betagro Ventures Corporate Venture Capital Minority
Elevate Ventures Venture Capital Minority
Gates Foundation Not-For-Profit Venture Capital
You’re viewing 5 of 11 investors. Get the full list »

BiomEdit Acquisitions (1)

BiomEdit’s most recent deal was a Merger/Acquisition with Folium Science. The deal was made on 25-Aug-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Folium Science 25-Aug-2026 Merger/Acquisition Other Agriculture
To view BiomEdit’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

BiomEdit FAQs

  • When was BiomEdit founded?

    BiomEdit was founded in 2022.

  • Where is BiomEdit headquartered?

    BiomEdit is headquartered in Indianapolis, IN.

  • What is the size of BiomEdit?

    BiomEdit has 30 total employees.

  • What industry is BiomEdit in?

    BiomEdit’s primary industry is Biotechnology.

  • Is BiomEdit a private or public company?

    BiomEdit is a Private company.

  • What is BiomEdit’s current revenue?

    The current revenue for BiomEdit is .

  • How much funding has BiomEdit raised over time?

    BiomEdit has raised $55.1M.

  • Who are BiomEdit’s investors?

    Bezos Earth Fund, AgriZeroNZ, Betagro Ventures, Elevate Ventures, and Gates Foundation are 5 of 11 investors who have invested in BiomEdit.

  • Who are BiomEdit’s competitors?

    Native Microbials, Bactolife, Novobind, AnimalBiome, and Resilient Biotics are some of the 8 competitors of BiomEdit.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process